This inventor holds 2 USPTO granted patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2000-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaragi-ken, JP (2000)
- Tsukuba, JP (2012)
Company Filing History:
Years Active: 2000-2012
Title: Noriyuki Kuzumaki: Innovator in Iontophoresis Technology
Introduction
Noriyuki Kuzumaki is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of iontophoresis, a technique used for drug delivery through the skin. With a total of 2 patents, Kuzumaki's work has advanced the understanding and application of this technology.
Latest Patents
Kuzumaki's latest patents include a composition and device structure for iontophoresis. This device structure provides an electrode and an electrically conductive layer. The electrically conductive layer contains an active ingredient and a basic water-swelling methacrylate copolymer. Additionally, the electrode and electrically conductive layer are placed into a hollow backing, with the electrode terminal connected to the electrode through the backing. An adhesive layer is set around the backing, and a liner to be removed when using the device is placed to cover the hollow of the backing. Another patent focuses on the iontophoresis system and its control process of current.
Career Highlights
Kuzumaki is currently employed at Hisamitsu Pharmaceutical Company, Inc., where he continues to innovate in the field of medical devices. His work has been instrumental in developing effective drug delivery systems that enhance patient care.
Collaborations
Kuzumaki has collaborated with notable colleagues, including Naruhito Higo and Kenji Mori. Their combined expertise has contributed to the advancement of iontophoresis technology.
Conclusion
Noriyuki Kuzumaki's contributions to iontophoresis technology exemplify his dedication to innovation in the medical field. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile